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In this study, we showed that cyanocobalamin dodecylamine, a ribose 50-carbamate derivative of
cyanocobalamin, was absorbed and accumulated to signiﬁcant levels by Caenorhabditis elegans
and was not further metabolized. The levels of methylmalonic acid and homocysteine, which serve
as indicators of cobalamin deﬁciency, were signiﬁcantly increased in C. elegans treated with the
dodecylamine derivative, indicating severe cobalamin deﬁciency. Kinetic studies show that the
afﬁnity of the cyanocobalamin dodecylamine derivative was greater for two cobalamin-dependent
enzymes, methylmalonyl-CoA mutase and methionine synthase, compared with their respective
coenzymes, suggesting that the dodecylamine derivative inactivated these enzymes. The dodecyl-
amine derivative did not affect the levels of mRNAs encoding these enzymes or those of other
proteins involved in intercellular cobalamin metabolism, including methylmalonyl-CoA mutase
(mmcm-1), methylmalonic acidemia cobalamin A complementation group (mmaa-1), methylma-
lonic aciduria cblC type (cblc-1), and methionine synthase reductase (mtrr-1). In contrast, the level
of the mRNAs encoding cob(I)alamin adenosyltransferase (mmab-1) was increased signiﬁcantly and
identical to that of cobalamin-deﬁcient C. elegans. These results indicate that the cyanocobalamin-
dodecylamine derivative acts as a potent inhibitor of cobalamin-dependent enzymes and induces
severe cobalamin deﬁciency in C. elegans.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cobalamin (vitamin B12, Cbl), an essential nutrient for humans,
undergoes a complex process of gastrointestinal absorption when
provided in the diet [1,2]. After uptake by its target cells, Cbl is
converted into 50-deoxyadenosylcobalamin (AdoCbl) and methyl-
cobalamin (CH3-Cbl), which function as coenzymes for methylmal-
onyl-CoA mutase (MCM; EC 5.4.99.2) [3] and methionine synthase(MS; EC 2.1.1.13) [4], respectively. The major symptoms of Cbl
deﬁciency are megaloblastic anemia and neuropathy [5], and the
underlying cause(s) of the associated developmental disorders,
metabolic abnormalities, and neuropathy are poorly understood
[6].
Animal models of Cbl deﬁciency are required for investigating
the molecular mechanisms of these metabolic disorders; however,
they are difﬁcult to establish, because animals (e.g., rats) must be
fed a Cbl-deﬁcient diet for long periods to achieve Cbl deﬁciency
[7]. Our recent study indicates that Caenorhabditis elegans grown
under conditions of Cbl deﬁciency for ﬁve generations (approxi-
mately 15 days) develops severe Cbl deﬁciency associated with
various phenotypes that include decreased egg-laying capacity
(infertility), prolonged life cycle (growth retardation), and reduced
lifespan [8]. These phenotypes resemble those of Cbl-deﬁcient
mammals.
McEwan et al. [9] synthesized ribose 50-carbamate derivatives
of cyanocobalamin (CN-Cbl) and demonstrated high-afﬁnity bind-
ing of intrinsic factor (IF, the gastric Cbl-binding protein) to certain
alkylamine derivatives. Our preliminary experiments indicate that
Table 1
Contents of CN-Cbl and the CN-Cbl dodecylamine derivative in worms.
CN-Cbl CN-Cbl dodecylamine derivative
(ng/g wet weight)
Control worms 132.2 ± 26.7 –
Treated worms 46.5 ± 7.8 110.0 ± 17.2
Control and treated worms were grown on plates containing CN-Cbl- and CN-Cbl
dodecylamine derivative-supplemented (each at 100 lg/L) M9 media for 3 days,
respectively. Corrinoids were extracted from the treated worms by boiling with
KCN at acidic pH. CN-Cbl and the CN-Cbl dodecylamine derivative were separated
each other using a Sep-Pak Plus C18 cartridge and their levels were determined
using the microbiological assay and HPLC, respectively. Data represent the
mean ± SD of ﬁve independent experiments.
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certain microorganisms that require Cbl for growth, such as Esche-
richia coli 215, Lactobacillus delbrueckii subsp. lactis ATCC 7830, and
Euglena gracilis Z. Further, CN-Cbl dodecylamine derivative signiﬁ-
cantly decreases the levels of Cbl-dependent enzymes in mamma-
lian cells cultured in vitro. Therefore, development of animal
models of Cbl deﬁciency may be facilitated if the dodecylamine
derivative acts as a potent inhibitor of Cbl-dependent enzymes.
In the present study, we show that CN-Cbl dodecylamine deriva-
tive potently inhibited the Cbl-dependent enzymes MCM and MS
of C. elegans.
2. Results and discussion
2.1. Effects of the CN-Cbl dodecylamine derivative on Cbl-related
biomarkers of C. elegans
Although McEwan et al. [9] demonstrated high afﬁnity binding
of the gastric Cbl-binding protein IF to the CN-Cbl dodecylamine
derivative (Fig. 1), our preliminary experiments indicated that this
derivative was inactive in Cbl-dependent microorganisms typically
employed in Cbl the bioassay. The dodecylamine derivative signif-
icantly inhibited the activities of Cbl-dependent enzymes (MCM
and MS) in mammalian cells cultured in vivo (our unpublished
data). Therefore, we evaluated effects of the CN-Cbl dodecylamine
derivative on Cbl-related phenotypes using C. elegans as a model.
Table 1 shows the concentrations of Cbl and its dodecylamine
derivative in homogenate prepared from adult worms grown in
the presence of the CN-Cbl derivative for 3 days. Remarkably, the
Cbl concentration of worms grown in the presence of the CN-Cbl
derivative was only 35% compared with that of control worms
and was similar to that of worms grown for two generations
(6 days) in the absence of Cbl [8]. In contrast, the CN-Cbl dodecyl-
amine derivative was absorbed and accumulated by worms grown
in the presence of the CN-Cbl derivative (approximately 110 ng/g
wet weight). These results suggest that the CN-Cbl dodecylamine
derivative did not inhibit the uptake of Cbl in the intestine, but it
was readily accumulated in worms and signiﬁcantly decreased
their Cbl concentrations.B
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Fig. 1. Structures of cyanocobalamin and its dodecylamine deTo determine whether the dodecylamine derivative detected in
the treated worms was converted into other forms of Cbl, corrinoid
compounds were extracted using 80% (v/v) ethanol from worms
grown in the presence of the dodecylamine derivative and analyzed
using reversed-phase HPLC. The retention times of authentic OH-
Cbl, CN-Cbl, AdoCbl, CH3-Cbl, OH-Cbl dodecylamine, CN-Cbl dode-
cylamine, and AdoCbl dodecylamine were 3.5, 8.1, 9.5, 12.8, 22.0,
30.6, and 36.2 min, respectively (Fig. 2A–D). The compounds
extracted from worms exposed to the derivative eluted with reten-
tion times of 3.8–30.3 min (Fig. 2E). Amajor peakwith the retention
time of 30.3 min was identical to that of authentic CN-Cbl dodecyl-
amine, and peaks were not detected with retention times of CN-Cbl
(8.1 min), OH-Cbl dodecylamine (22.0 min), or AdoCbl dodecyl-
amine (36.2 min). These results indicate that the CN-Cbl dodecyl-
amine derivative accumulated by worms was not converted to
any other Cbl-related compound, including its coenzyme forms.
The levels of MMA and Hcy were assayed in C. elegans grown for
3 days in the presence of the CN-Cbl dodecylamine derivative
(Fig. 3A and B). The levels of both indicators were signiﬁcantly
increased in worms exposed to the dodecylamine derivative com-
pared with those of the control worms. The increased MMA and
Hcy levels were identical to those of Cbl-deﬁcient worms. These
results show that the worms developed severe Cbl deﬁciency when
they were treated with the CN-Cbl dodecylamine derivative for
only 3 days.N
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Fig. 2. HPLC analysis of Cbl compounds detected in worms treated with the CN-Cbl
dodecylamine derivative. Cbl analogs were analyzed using HPLC as described in
Section 3. (A) Authentic Cbl compounds. Retention times of OH-Cbl, CN-Cbl, AdoCbl,
and CH3-Cbl were 3.5, 8.1, 9.5, 12.8 min, respectively. (B) OH-Cbl dodecylamine
derivative. The retention time of the OH-Cbl derivative was 22.0 min. (C) CN-Cbl
dodecylamine derivative. The retention time of the CN-Cbl dodecylamine derivative
was 30.6 min. (D) AdoCbl dodecylamine derivative. The retention time of the
AdoCbl derivative was 36.2 min. (E) Corrinoid compounds detected in the worms
grown in the presence of the CN-Cbl dodecylamine derivative.
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Fig. 3. Methylmalonic acid and homocysteine contents of worms treated with the
CN-Cbl dodecylamine derivative. (A) Methylmalonic acid (MMA) and (B) homocys-
teine (Hcy) were measured in cell homogenates of worms grown in the presence of
CN-Cbl (control; 1, black bar), the CN-Cbl dodecylamine derivative (2, white bar), or
Cbl-deﬁcient worms (3, shaded bar). Data represent the mean ± SD of ﬁve
independent experiments. The different letters indicate values that are signiﬁcantly
different, p < 0.05.
724 T. Bito et al. / FEBS Open Bio 4 (2014) 722–7292.2. Effects of the CN-Cbl dodecylamine derivative on Cbl-dependent
enzymes in C. elegans
The increased levels of MMA and Hcy in worms exposed to the
CN-Cbl dodecylamine derivative indicate that the activities of
MCM and MS were signiﬁcantly inhibited by the accumulation of
the CN-Cbl derivative. To determine whether the dodecylamine
derivative inhibited these Cbl-dependent enzyme activities,
homogenates of worms grown in the presence (control) or absence
of Cbl or in the presence of the derivative were assayed for MCM
and MS activities. The holo-MCM and MS activities of the worms
treated with the dodecylamine derivative decreased to approxi-
mately 8% (Fig. 4A) and 18% (Fig. 4B), respectively, compared with
those of control worms.
To deﬁne the mechanism of inhibition of MCM by the CN-Cbl
derivative, we determined the effects of the CN-Cbl derivative on
apo-MCM activity of worms in the presence or absence of AdoCbl
(Fig. 5). The apparent Km value of the worm apoenzyme was
4.7 lM for AdoCbl. The CN-Cbl dodecylamine derivative
competitively inhibited the apoenzyme. The Ki value of the worm
apoenzyme was 1.5 lM for CN-Cbl dodecylamine derivative, which
has increased afﬁnity for the apoenzyme relative to that of AdoCbl.
CN-Cbl did not reduce the apo-MCM activity in the presence of
AdoCbl.
Our previous study shows that the holo-MS present in Cbl-sup-
plemented or -deﬁcient worms accounts for most MS activity [8].
To determine whether holo-MS activity was inhibited by the
addition of CN-Cbl dodecylamine derivative, MS activity was
assayed in a homogenate of the control worms in the presence of
1 2 3
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Fig. 4. Cbl-dependent enzyme (methylmalonyl-CoA mutase and methionine syn-
thase) activities in worms treated with the CN-Cbl dodecylamine derivative. Holo-
methylmalonyl-CoA mutase (MCM) (A) and holo-methionine synthase (MS) (B)
activities were measured in cell homogenates prepared from worms grown in the
presence of CN-Cbl (control; 1, black bar), the CN-Cbl dodecylamine derivative (2,
white bar), or Cbl-deﬁcient worms (3, shaded bar). Data represent the mean ± SD of
ﬁve independent experiments; the different letters indicate values that are
signiﬁcantly different, p < 0.05.
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Fig. 5. Effects of the CN-Cbl dodecylamine derivative on the enzyme activity of C.
elegans apo-MCM in the presence of AdoCbl. A cell homogenate of worms grown
under conditions of Cbl deﬁciency was used as an apo-MCM preparation. MCM
activity was assayed in the reaction mixture containing various concentrations (0, 2,
5, 10 lM) of the CN-Cbl dodecylamine derivative in the presence of j 2.5 lM, N
5.0 lM, or d 10.0 lM of AdoCbl. MCM activity data were analyzed using the Dixon
plot. Data represent the mean ± SD of three independent experiments.
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Fig. 6. Effects of the CN-Cbl dodecylamine derivative on the activity of the C. elegans
holo-MS. A cell homogenate of worms grown in the presence of CN-Cbl (control)
was used as a holo-MS preparation. MS activity was assayed in the presence of
various concentrations (0, 1, 3, 5, and 10 lM) of CN-Cbl (j) or the CN-Cbl
dodecylamine derivative (s). Data represent the mean ± SD of three independent
experiments; the different letters indicate values that are signiﬁcantly different,
p < 0.05.
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Fig. 7. Levels of mRNA and protein of MS in worms treated with the CN-Cbl
dodecylamine derivative. (A) qPCR analysis of the mRNA levels of MS in homog-
enates of worms exposed to CN-Cbl (control; 1, black bar), the CN-Cbl dodecyl-
amine derivative (2, white bar) or Cbl-deﬁcient worms (3, shaded bar). (B) Western
blot analysis using an anti-MS antibody of homogenates (100 lg of protein)
prepared from worms exposed to CN-Cbl (control; 1), the CN-Cbl dodecylamine
derivative (2), or Cbl-deﬁcient worms (3) was treated by SDS–polyacrylamide slab
gel electrophoresis followed by immunoblotting with an anti-MS antibody.
Immunoreactive components were visualized using an immunoblot-staining kit
for peroxidase.
T. Bito et al. / FEBS Open Bio 4 (2014) 722–729 725the dodecylamine derivative (Fig. 6). CN-Cbl did not inhibit holo-
MS activity. In contrast, the dodecylamine derivative signiﬁcantly
inhibited enzyme activity in a dose-dependent manner, and
enzyme activity was completely inhibited in the presence of10 lM dodecylamine. These results suggest that the CN-Cbl deriv-
ative is exchanged for CH3-Cbl bound to MS, inhibiting enzyme
activity.
These results indicate that the afﬁnity of CN-Cbl dodecylamine
derivative is higher for MCM compared with that of AdoCbl and
that the inhibitions of MCM and MS activities are attributable to
the formation of inactive CN-Cbl derivative-enzyme complexes.
Yamada et al. demonstrated that most MS activity is derived
from the holo-enzyme in normal or Cbl-deﬁcient rats because
the apo-enzyme is very unstable [10]. Although MS protein levels
in liver extracts of Cbl-deﬁcient rats are signiﬁcantly decreased
compared with those of control rats, the level of the mRNA encod-
ing MS is not affected by the Cbl concentration of rat livers [10]. To
determine the changes in MS protein and mRNA levels (metr-1) of
worms treated with the CN-Cbl derivative, we conducted western
blot and qPCR analyses and found that the level of mRNA was
unchanged (Fig. 7A), whereas the level of MS protein in Cbl-
deﬁcient worms was reduced to approximately 32% compared
with that of controls. This result differs from the detection of an
extremely faint band of MS in the livers of Cbl-deﬁcient rats,
suggesting that the worm apo-enzyme is not very unstable. The
726 T. Bito et al. / FEBS Open Bio 4 (2014) 722–729intensity of the MS protein band in extracts prepared from worms
treated with the CN-Cbl derivative was identical to that of the con-
trols (Fig. 7B). These results suggest that the binding of the CN-Cbl
derivative to MS completely inhibited MS activity and did not
affect the level of MS protein.
2.3. Effects of the CN-Cbl dodecylamine derivative on the levels of
mRNAs encoding proteins involved in Cbl metabolism in C. elegans
To evaluate the effects of the CN-Cbl derivative on the levels of
mRNAs encoding proteins involved in Cbl metabolism, we per-
formed qPCR analyses to detect mRNAs encoding MCM (mmcm-
1), methylmalonic acidemia Cbl A complementation group; MMAA
(mmaa-1), cob(I)alamin adenosyltransferase; MMAB (mmab-1),
methylmalonic aciduria cblC type; MMACHC (cblc-1), and
methionine synthase reductase; MSR (mtrr-1). The mRNA levels
of mmaa-1, cblc-1, and mtrr-1 did not differ signiﬁcantly among
three experimental conditions (Fig. 8A, B, D, and E). However, the
levels of mmab-1 mRNA of worms treated with the CN-Cbl deriva-
tive was signiﬁcantly increased compared with that of the control
worms, and the increased level was identical to that of Cbl-deﬁ-
cient worms (Fig. 8C).
2.4. Effects of the CN-Cbl dodecylamine derivative on the C. elegans
egg-laying capacity and life cycle
Our previous study demonstrates that Cbl deﬁciency decreases
the egg-laying rates and prolongs the life cycle of C. elegans [8]. Inm
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Fig. 8. Levels of mRNAs encoding proteins involved in Cbl metabolism in worms treated
mRNAs encoding (A) methylmalonyl-CoA mutase, MCM; (B) methylmalonic aciduria typ
orthlog of human cob(I)alamin adenosyltransferase in C. elegans); (D) Cbl deﬁciency C c
reductase, MSR in worms treated with CN-Cbl (control; 1, black bar), the CN-Cbl dode
represent the mean ± SD of three independent experiments. The letters indicate valuesthe present study, the egg-laying rates of worms exposed to the
CN-Cbl dodecylamine derivative were signiﬁcantly decreased
(Fig. 9A), and the life cycle was increased, but the difference was
not statistically signiﬁcant (Fig. 9B). These results suggest that
increased Cbl deﬁciency, long exposure to Cbl-deﬁcient conditions,
or both are necessary to signiﬁcantly prolong life cycle.
These results indicate that the CN-Cbl dodecylamine derivative
acts a potent inhibitor of Cbl-dependent MCM and MS activity,
which leads to metabolic disorders caused by Cbl deﬁciency.
Chandler et al. [11] described that MMA level was approxi-
mately 3 times greater in C. elegans treated with RNA interference
against mmcm-1, mmaa-1, and mmab-1 than in the wild-type
worms and that the mmcm-1deletion mutant accumulated
17 times more MMA than the wild-type worms after propionic
acid loading. In this study, MMA level was approximately 4 times
greater in Cbl-deﬁcient and CN-Cbl derivative-treated worms than
in the control worms (Fig. 3A); the magnitude of MMA elevation
was similar to that of the worms treated with RNA interference
against mmcm-1.
Our previous study [8] indicated that MS is more sensitive to
cellular Cbl concentrations of C. elegans than MCM, suggesting that
the phenotype observed in this and previous studies would rather
be attributable to the results of impaired remethylation via the MS
reaction than those of perturbed propionyl-CoA oxidation in the
MCM pathway.
CN-Cbl [c-lactam], a CN-Cbl analog with a modiﬁed C-ring side
chain inhibits the MS activity of cultured HL-60 cells to induce cell
death but does not affect MCM activity [12]. However, Sponne et al.0
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cylamine derivative (2; white bar), and Cbl-deﬁcient worms (3; shaded bar). Data
that are signiﬁcantly different, p < 0.05.
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Fig. 9. Egg-laying capacity and the length of the life cycle of worms treated with the
CN-Cbl dodecylamine derivative. Egg numbers per day per worm (A) and length (h)
of the life cycle (B) of worms treated with CN-Cbl (control; 1, black bar), CN-Cbl
dodecylamine derivative (2, white bar), and Cbl-deﬁcient worms (3, shaded bar).
Data represent the mean ± SD of ﬁve independent experiments. The letters indicate
values that are signiﬁcantly different, p < 0.05.
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a culture medium of rat oligodendrocytes and incubated for
25 days, MMA and Hcy were approximately 200 times and twice
greater, respectively, in OH-Cbl [c-lactam]-treated cells than in
the control cells.
Subcutaneous administration of OH-Cbl [c-lactam] to rats
causes Cbl deﬁciency because plasma MMA was approximately
331 times and twice greater in the treated rats than in the control
and Cbl-deﬁcient rats, respectively [14]. Hepatic holo-MCM and
MS activities of OH-Cbl [c-lactam]-treated rats decreased to
approximately 65% and 43% of the control activities, respectively,
indicating that OH-Cbl [c-lactam] potently inhibits mammalian
Cbl-dependent enzymes [15].
However, high concentrations of OH-Cbl [c-lactam] must be
administered for several weeks using osmotic mini-pumps to pro-
duce Cbl-deﬁcient rats [9] because of poor binding to IF [15]. Com-
pared with OH-Cbl [c-lactam], the CN-Cbl dodecylamine derivative
is easy to prepare and acts a potent inhibitor of both MCM and MS.
Moreover, this compound shows high afﬁnity binding of IF [9].
These properties of the CN-Cbl dodecylamine derivative suggest
that Cbl deﬁciency in mammals may be readily induced by oral
or intravenous administration of this compound.
3. Materials and methods
Chemicals: CN-Cbl, 1,10-carbonyldiimidazole, and dodecylamine
were purchased from Wako Pure Chemical Industries (Osaka,
Japan). Phenyl-Toyopearl 650 M was purchased from Tosoh Corpo-
ration (Tokyo, Japan).
3.1. Organisms and culture conditions
The N2 Bristol wild-type C. elegans strain was maintained at
20 C on nematode growth medium (NGM) plates using E. coli
OP50 as the food source [16]. To induce dietary Cbl deﬁciency,
worms were grown on 1.7% (w/v) agar plates containing M9 med-
ium (3 g/L KH2PO4, 6 g/L Na2HPO4, 0.5 g/L NaCl, 1 g/L NH4Cl,
1 mmol/L MgSO4, 50 lmol/L CaCl2, 2 g/L glucose, 4 mg/L thiamine
hydrochloride, and 5 mg/L cholesterol) in l L water. Each plate con-
taining M9-medium supplemented with Cbl (100 lg/L CN-Cbl)
received one egg obtained from worms grown on NGM plates with
Cbl-deﬁcient E. coli OP50 [8]. Eggs were allowed to hatch and
develop into reproductively active adults. The adults were then
removed from each plate, eggs were collected, and each egg was
transferred onto a new control plate. After this procedure was
repeated at least 10 times, the worms were used as controls. Cbl-
deﬁcient worms were prepared as described previously [8].3.2. Preparation of the CN-Cbl dodecylamine derivative
The CN-Cbl dodecylamine derivative was prepared according to
the method by McEwan et al. [9]. In brief, solid 1,10-carbonyldiim-
idazole (26 mg) was added to CN-Cbl (0.1 g) dissolved in dimethyl
sulfoxide (1.2 mL) at 30 C, and the mixture was stirred for 25 min.
Dodecylamine (0.27 mmol) was added to the mixture and then
stirred for 24 h at 25 C. The Cbl compound was extracted twice
from the mixture with 2 mL of phenol/dichloromethane (1:2, v/v)
and then re-extracted twice from the combined phenol fractions
with 2 mL of distilled water. The water-soluble fractions were
combined and chromatographed using a TSK gel-Toyopearl
650 M column (2.4  24 cm) equilibrated with 250 mL of 25%
(v/v) ethanol. Unreacted and modiﬁed CN-Cbl compounds were
eluted with 250 mL of 25% (v/v) and 60% (v/v) ethanol. The frac-
tions containing products were combined, the solvent was evapo-
rated under reduced pressure, and the residue was dissolved in
5 mL of 80% (v/v) ethanol. The product was further puriﬁed using
silica-gel 60 TLC with the solvent 1-butanol:2-propanol:water
(10:7:10, v/v/v). After drying the TLC sheet, the CN-Cbl derivative
was collected, extracted with 80% (v/v) methanol, and the solvent
was evaporated under reduced pressure. The residue was dissolved
in a small amount of 18% (v/v) acetonitrile and then puriﬁed using
a reversed-phase high performance liquid chromatography (HPLC)
column (Wakosil-II 5C18RS, u 4.6  150 mm) and a Shimadzu
HPLC system (SCL-10A VP System controller, DGU-20A 3R Degas-
sing unit, LC-20AB Liquid chromatograph, SPD-20A UV/VIS detec-
tor, and CTO-20AC Column oven). The CN-Cbl derivative was
eluted with a linear gradient of acetonitrile (18–28% for 8.5 min
and 28–100% for 13 min, 1.0 mL/min) at 40 C and monitored by
measuring absorbance at 254 nm. The peak fraction was collected,
the solvent was evaporated under reduced pressure, and the resi-
due was used for the following experiments. The puriﬁed dodecyl-
amine derivative of CN-Cbl (approximately 94% purity) was
dissolved in distilled water, and its concentration was determined
at k361 (e = 13,000) as described previously [9].
3.3. Preparation of C. elegans treated with CN-Cbl dodecylamine
derivative
Control worm eggs were transferred to and hatched on an M9
plate containing the CN-Cbl derivative (100 lg/L) and E. coli OP50
and grown to maturity.
3.4. Determination of the levels of CN-Cbl and its derivative in C.
elegans
Worms grown in the absence or presence of CN-Cbl or its dode-
cylamine derivative were harvested and incubated for 1 h at 20 C
in fresh M9 medium to remove any residual E. coli. The washed
worms (1.0 g wet weight) were homogenized in 0.5 mL of
100 mmol/L potassium phosphate buffer (pH 7.0) at 4 C using a
manual homogenizer (AS ONE Corp., Osaka, Japan) and sonicated
(6 kHz for 60 s) 3 times on ice. The worm homogenate was resus-
pended in 25 mL of 57 mmol/L sodium acetate buffer (pH 4.8) con-
taining 0.05% (w/v) KCN, boiled for 30 min, and centrifuged at
15,000g for 15 min at 4 C. The Cbl content of the supernatant
fraction was determined using a microbiological assay employing
L. delbrueckii subsp. lactis ATCC 7830 as described previously [17].
CN-Cbl and the Cbl derivative were extracted from treated
worms using the same conditions as described above. The superna-
tant fraction (20 mL) that was chromatographed using a Sep-Pak
Plus C18 cartridge (Waters Corp., Milford, MA, USA) to separate
the CN-Cbl derivative from CN-Cbl. After the cartridge was washed
with 10 mL of distilled water, CN-Cbl and the CN-Cbl derivative
were eluted sequentially with 10 mL of 20% (v/v) ethanol solution
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was evaporated under reduced pressure and then dissolved in
100 lL of distilled water. CN-Cbl was determined using the
microbiological Cbl assay method described above, and the CN-
Cbl derivative was assayed using a Shimadzu HPLC system (SCL-
10A VP System controller, DGU-20A 3R Degassing unit, LC-20AB
Liquid chromatograph, SPD-20A UV/VIS detector, and CTO-20AC
column oven) with a CDS ver. 5 chromato-data processing system
(LAsoft Ltd., Chiba, Japan). Samples (20 lL) were chromatographed
using a reversed-phase HPLC column (Wakosil-II 5C18RS, u
4.6  150 mm) and eluted (1.0 mL/min) with a linear gradient of
methanol (20–90% for 30 min) containing 1% (v/v) acetic acid at
40 C. The Cbl derivative was monitored by its absorbance at
254 nm, and its retention time was 30.3 min.
3.5. Determination of coenzyme forms of the Cbl-dodecylamine
derivative
All procedures were performed in the dark. Hydro (OH)- and
adenosyl (Ado)-forms of the Cbl-dodecylamine derivative were
prepared from the CN-Cbl derivative. In brief, the CN-Cbl dodecyl-
amine derivative was dissolved in distilled water, bubbled with
nitrogen gas for 30 min, reduced with sodium tetrahydroborate
until the solution turned dark brown, and neutralized with
1.0 mol/L HCl. Most of the CN-Cbl derivative was converted to
the OH-Cbl dodecylamine derivative. To prepare AdoCbl dodecyl-
amine derivative, a small amount of 50-iodo-50-deoxyadenosine
was added to the reduced form of the Cbl dodecylamine derivative,
and this solution was neutralized as described above. The neutral-
ized preparations were desalted using a Sep-Pak Vac 20 cc (5 g)
C18 cartridge (Waters Corp.), and the desalted and concentrated
solutions were treated with silica-gel 60 TLC as described above
to separate the OH- or Ado-form of the dodecylamine derivative
and unmodiﬁed CN-Cbl dodecylamine derivative. After drying the
TLC sheet, the OH- or Ado-form of the dodecylamine derivative
was collected, extracted with 80% (v/v) ethanol, and the solvent
was evaporated to dryness under reduced pressure. Each residue
was dissolved in a small amount of distilled water and used as
the authentic OH-Cbl dodecylamine or AdoCbl dodecylamine
derivatives. We were unable to prepare a CH3-Cbl dodecylamine
derivative with high purity.
To extract Cbl derivatives, including its coenzyme forms from
worms, 100 mL of 80% (v/v) ethanol was added to lyophilized sam-
ples of worms treated with the CN-Cbl dodecylamine derivative.
The samples were heated at 98 C for 30 min under reﬂux and
cooled to room temperature [18], centrifuged at 10,000g for
10 min, and the supernatant was evaporated under reduced pres-
sure. The residue was dissolved in 5 mL of distilled water and cen-
trifuged at 10,000g for 10 min to remove insoluble material. The
supernatant fraction was chromatographed a Sep-Pak Plus C18 car-
tridge, which was washed with 10 mL of distilled water and eluted
with 2 mL of ethanol. The ethanol elute was evaporated under
reduced pressure and the residue was dissolved in 100 lL of
distilled water. The levels of coenzyme forms of the Cbl dodecyl-
amine derivative in worms treated with the CN-Cbl dodecylamine
derivative were determined using HPLC as described above. The
retention times of OH-, CN, and Ado-forms of Cbl dodecylamine
derivatives were 22.0, 30.6, and 36.2 min, respectively.
3.6. Assays for Cbl-related biomarkers
The worms (1.0 g wet weight) grown as described above,
washed with fresh M9 medium, homogenized in 0.5 mL of
100 mmol/L potassium phosphate buffer (pH 7.0) at 4 C using a
manual homogenizer (AS ONE), and sonicated 3 times on ice. Each
homogenate was centrifuged at 15,000g for 15 min at 4 C, andthe supernatant was used as a crude homogenate for assaying
Cbl-related biomarkers. The levels of methylmalonic acid (MMA)
[19] and homocysteine (Hcy) [20], two indicators of Cbl deﬁciency,
were determined using HPLC as described above. Cbl-dependent
enzyme (MCM and MS) activities were assayed using published
methods [21,22]. Total enzyme (holoenzyme and apoenzyme)
and holoenzyme activities were determined in the presence or
absence of Cbl coenzymes (AdoCbl for MCM and CH3-Cbl for MS).
3.7. Inhibition of MCM and MS activities by the CN-Cbl dodecylamine
derivative
Our previous study [8] showed that the levels of apo-MCM are
increased up to approximately 97% of the total MCM (holo- and
apo-MCMs) in Cbl-deﬁcient worms. Thus, a cell homogenate of
Cbl-deﬁcient worms was used as an apo-MCM preparation in the
following experiments. Lineweaver–Burk analysis was used to
determine the Km value of worm MCM for AdoCbl in reaction
mixtures containing 0, 2.5, 5, and 10 lM of AdoCbl. Dixon plots
[23] were used to determine the apparent Ki value of MCM in
reaction mixtures containing 0, 1, 3, 5, and 10 lM of CN-Cbl or
its dodecylamine derivative.
A cell homogenate of Cbl-supplemented (control) worms was
used as a holo-MS enzyme preparation, because most MS activity
is derived from the holoenzyme in Cbl-supplemented or -deﬁcient
worms [8]. Holo-MS activity was determined in reactions contain-
ing 0, 1, 3, 5, and 10 lM of CN-Cbl or its dodecylamine derivative.
3.8. Western blotting
Worms grown in the absence of CN-Cbl or in the presence of
CN-Cbl or the CN-Cbl dodecylamine derivative were homogenized
in 100 mmol/L potassium phosphate buffer (pH 7.0) at 4 C. Each
homogenate was centrifuged at 15,000g for 10 min and the
supernatant fraction was analyzed. We used a precast slab gel
(PAGEL, type NPG-520L, ATTO Corporation, Tokyo, Japan) for elec-
trophoresis of samples through a 5–20% (w/w) linear gradient of
polyacrylamide in the presence of SDS. After electrophoresis,
proteins were transferred to a PVDF membrane (Immuno-Blot
PVDF, Bio-Rad Laboratories Inc., Hercules, CA, USA) in a Trans-Blot
SD semi-dry electrophoretic transfer cell (Bio-Rad). The PVDF
membrane was probed with an anti-MS antibody (ab66039,
abcam, Cambridge, MA, USA). We performed the immunodetec-
tion reactions using an anti-mouse IgG antibody secondary anti-
body (Promega KK, Tokyo, Japan) coupled to horseradish
peroxidase and an immunoblot-staining kit for peroxidase
(EzWestBlue, ATTO), according to the manufacturer’s instructions.
A Protein Ladder One Triple-color kit (Nacalai Tesque Inc., Kyoto,
Japan) was used to determine molecular mass. After the treated
PVDF membrane was photographed using a digital camera (Cool-
pix 4300, Nikon, Japan), the intensities of the protein bands were
calculated of Image J software [24].
3.9. Quantitative PCR analysis (qPCR)
Total RNA was prepared from worms using Sephasol-RNA1
(Nacalai Tesque). Poly(A)+ mRNA prepared from total RNA using
the Poly (A)+ Isolation kit from Total RNA (Nippon Gene, Tokyo,
Japan) was used to synthesize cDNA using PrimeScript™ II 1st
Strand cDNA Synthesis kit (Takara Bio, Otsu, Japan). Primer pairs
used for qPCR analysis were designed using GENETYX software
(GENETYX Corporation, Tokyo, Japan) (Table 2). Gene-speciﬁc
primers were selected such that the resulting PCR products were
approximately 100 bp. A CFX Connect™ Real-Time System
(Bio-Rad) with SYBR Premix Ex Taq (Takara Bio) was used to per-
form qPCR. The level of the mRNA encoding b-actin was used as
Table 2
Primer pairs used for the qPCR analysis.
Gene symbol Primer sequences (50–30)
mmcm-1 ATTAAAGCAGGGCAGCAAGGAC and
GGCACGGATATGGTTCAACTTGG
metr-1 AAAGACCACGACAAGCCACTGA and
CGCTTGATGATTCGAGCACGTT
mmaa-1 TTGGAAAGAAGGCGACAGGA and
TTGTTTCTGCAGCCAGACCA
mmab-1 GCTCTTCTGATTTGGGAAGAGG and
CGACGCTCATTGTTGTACAGAG
cblc-1 ATGTTGCTGGAGCAGCTTTC and
AGTGTCCACCGTAGATTGGATG
mtrr-1 AAGACCGCTGATTCGTGTACTC and
GCATGTCAGCCAATGACAATCC
act-1 TCCAAGAGAGGTATCCTTACCC and
CTCCATATCATCCCAGTTGGTG
Primer pairs for the qPCR were designed using GENETYX software. Each gene is
involved in the metabolisms of Cbl, including MCM (mmcm-1), MS (metr-1),
methylmalonic acidemia cobalamin A complementation group (mmaa-1),
cob(I)alamin adenosyltransferase (mmab-1), methylmalonic aciduria cblC type
(cblc-1), and MS reductase (mtrr-1). For normalization, b-actin (act-1) mRNA levels
served as the internal standard.
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3 times for each cDNA prepared from three preparations of worms.
3.10. Analysis of egg-laying capacity and life cycle
Measurements of egg-laying capacity were performed accord-
ing to the method by Byerly et al. [25]. Individual worms grown
in the presence of CN-Cbl, its dodecylamine derivative or in the
absence of Cbl were transferred to fresh plates containing the
respective culture media and incubated for 1 day at 20 C. After
laying eggs, each worm was removed from the plate, and the eggs
were counted in triplicate. The life cycle of worms grown under
each experimental condition was determined at 20 C using the
synchronization method by Johnson and Wood [26].
3.11. Protein quantitation
Protein concentrations were determined using the Bradford
method [27] with ovalbumin as a standard.
3.12. Statistical analysis
The effects of the CN-Cbl dodecylamine derivative on C. elegans
phenotypes were evaluated using one-way ANOVA with Tukey’s
multiple comparison test (GraphPad Prism 3 for Windows version
2.01; GraphPad Software Inc., La Jolla, CA, USA). All data are pre-
sented as the mean ± standard deviation (SD). Signiﬁcant differ-
ences were deﬁned as p < 0.05.Author contributions
T.B. and F.W. planned experiments; T.B. performed experi-
ments; T.B. and Y.Y. analyzed data; T.I. and T.K. contributed
reagents or other essential material; and T.B. and F.W. wrote the
paper.
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